The first vaccines to guard against therespiratory illness RSVwill soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots. The move, announced Thursday, followed a vote at ameetingof the CDC's Advisory Committee on Immunization Prac...
Kansas health care professionals say more education is needed regarding the vaccine for respiratory syncytial virus, or RSV. Kansas Health Institute hosted a virtual forum earlier this month to discuss the types of immunizations older adults might need and why those shot...
Other results are expected laterfrom studieson the safety and efficacy of co-administering Arexvy at the same time as other shots, like the stronger flu vaccines that are given annually to seniors. Arexvy is an adjuvanted vaccine, meaning that it combines its immunogen mimicking part of the ...
For adults 60 and older, RSV vaccines are showing continued protection even two years after immunization. Based on this, the U.S. Centers for Disease Control and Prevention recommends only one dose of the RSV vaccines for seniors right now but this may change. In infants, we know that the ...
Moderna is also developing a stand-alone flu shot, a personalized cancer vaccine with Merck andshots for latent viruses, among other products. Moderna has said it expects to return to sales growth in 2025 and to break even by 2026, with the launch of new p...
(When the survey was fielded, the FDA had already approved the vaccine for adults 60 and older, although the shots were not yet available.) The percentage of people who know, or don’t know, certain facts about RSV and vaccines against it. Credit: Annenberg Public Policy Center’s ASAPH ...
Committee members expressed worry about the fact that these vaccines will likely be given at the same time of the year as flu and Covid shots and it’s not yet clear if giving the vaccines at the same time undermines the immune responses they generate. ...
Zapata, at UCLA Health, said some insurers have insisted on prior authorizations for the shots, "which then delays the patient and puts them out of the window to get the vaccine." It is unclear how many pregnant people have been vaccinated. The CDC said it does not yet have enough data...
The U.S. has approved the first vaccine for RSV, shots to protect older adults. The respiratory virus filled hospitals with wheezing babies last fall but also endangers seniors. After decades of failure in developing an RSV vaccine, the Food and Drug Adm
The vaccine quest isn't just to protect infants. RSV is dangerous for older adults, too, and both Pfizer and rival GSK recently announced that their competing shots also proved protective for seniors. None of the findings will help this year when anearly RSV surgealready is crowding children'...